Table 4 Anemia and its associated factors after ART initiation in HIV positive patients attending Black Lion Specialized Hospital, Addis Ababa, Ethiopia, 2017
Variables | Anemia | Non anemic | X2 | P value | AOR (95% CI) |
|---|---|---|---|---|---|
Age(in years) | |||||
<30 | 7 (21.2%) | 26 (78.8%) | 6.23 | 0.05 | 4.01 (1.24–13.02) |
30–40 | 15 (13.3%) | 98 (86.7%) | 2.25 (0.84–5.98) | ||
>40 | 7 (6.4%) | 102 (93.6%) | 1.00 | ||
Sex | |||||
Male | 10 (9.3%) | 97 (90.7%) | 1.19 | 0.28 | 0.79 (0.34–1.85) |
Female | 19 (12.8%) | 129 (87.2%) | 1.00 | ||
ART regimen | |||||
TDF based | 21 (11.4%) | 164 (88.6%) | 0.000 | 0.99 | 0.99 (0.40–2.46) |
AZT based | 8 (11.4%) | 62 (88.6%) | 1.00 | ||
Cotrimoxazole | |||||
NO | 9 (8.9%) | 92 (91.1) | 1.01 | 0.32 | 0.74 (0.29–1.86) |
Yes | 20 (13%) | 134 (87) | 1.00 | ||
CD4 count (cells/mm3) | |||||
<200 | 10 (16.2%) | 52 (83.9%) | 2.62 | 0.27 | 2.04 (0.70–5.96) |
200–349 | 10 (12.2%) | 72 (87.8%) | 1.44 (0.52–3.99) | ||
≥350 | 9 (8.1%) | 102 (91.9%) | 1.00 | ||
BMI(Kg/m2) | |||||
<18.5 | 4 (12.9%) | 27 (87.1%) | 0.08 | 0.96 | 0.81 (0.21–3.17 |
18.5–24.9 | 18 (11.2%) | 143 (88.8%) | 0.76 (0.29–2.01) | ||
≥25 | 7 (11.1%) | 56 (88.9%) | 1.00 | ||